Registration Statement
Registration Statement. The Company's registration statement on Form S-3 (File Number 333-261530) registering the sale of the Securities by the Company to the Investor, including the documents incorporated by reference therein.
Found in
NaturalShrimp Inc contract
Registration Statement. One or more registration statements under the Securities Act of the Company covering the resale of the Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of the Registrable Securities, by such other means of distribution of Registrable Securities as the Holders may reasonably specify, in respect of which the Company may use a Form S-3 registration statement (or any successor registration statement...
View More
Found in
Cryptyde, Inc. contract
Registration Statement. The Company's Registration Statement on Form S-3 (File No. 333-263370), that became effective on March 14, 2022.
Found in
Terns Pharmaceuticals, Inc. contract
Registration Statement. The Company's Registration Statement on Form S-3 (File No. 333- 258448), automatically effective on August 4, 2021.
Found in
Nurix Therapeutics, Inc. contract
Registration Statement. The Company's registration statement on Form S-3 (File No. 333-248235), as amended by Amendment No. 1 filed on September 2, 2020 and effective on September 4, 2020.
Found in
Quotient Ltd contract
Registration Statement. The Company's Registration Statement on Form S-3 (File No. 333- 254057) as amended and, declared effective on April 13, 2022.
Found in
Scholar Rock Holding Corp contract
Registration Statement. Any registration statement filed by the Company on behalf of any Investors.
Registration Statement. Means the Company's Registration Statement on Form S-3 (File No. 333-263251), which was declared effective by the Commission on May 4, 2022.
Found in
Wave Life Sciences Ltd. contract
Registration Statement. A Form S-3 shelf registration statement on Form S-3 covering the registration and issuance of securities by the Company, including not less than 250% of Conversion Shares and Warrant Shares, pursuant to Rule 415 promulgated under the Securities Act. 4 The closing price of the Common Stock as reported on the Principal Market on the date of execution of this Agreement.
Found in
Net Element, Inc. contract
Registration Statement. The Company's Registration Statement on Form S-3 (File No. 333-258702), that became effective on August 23, 2021.
All Definitions
Found in
Inozyme Pharma, Inc. contract